Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384044 · ClinicalTrials.gov registry record · NA
A Pilot Clinical Study to Evaluate the Safety and Efficacy of Marketed Oxalate Strips Compared to a Marketed Safety Pen
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02384044 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 30 participants.
The verdict
NCT02384044, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This pilot study will evaluate the safety and effectiveness of a marketed sensitivity strip on existing dentinal hypersensitivity compared to a marketed sensitivity pen.
Interventions
- DEVICE Crest® Sensi-Stop™ Strips
- DEVICE Colgate® Sensitivity Relief Pen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02384044
The ClinicalTrials.gov registry entry for NCT02384044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Crest® Sensi-Stop™ Strips is the first listed.
NCT02384044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02384044 about?
NCT02384044 is a clinical study titled "A Pilot Clinical Study to Evaluate the Safety and Efficacy of Marketed Oxalate Strips Compared to a Marketed Safety Pen". This pilot study will evaluate the safety and effectiveness of a marketed sensitivity strip on existing dentinal hypersensitivity compared to a marketed sensitivity pen.
What is the current status of trial NCT02384044?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-02. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02384044?
The interventions under investigation include: Crest® Sensi-Stop™ Strips (DEVICE), Colgate® Sensitivity Relief Pen (DEVICE).
Who is sponsoring clinical trial NCT02384044?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.